Rochelle Summerfelt

Rochelle Summerfelt is an accomplished professional in the field of clinical development, currently serving as the Vice President of Clinical Development at Viridian Therapeutics, Inc. since December 2021. In addition, Rochelle is the Owner and President of Quality Research Services, LLC, where a range of independent clinical research services is provided. Prior experience includes holding senior leadership roles, such as Senior Director and Director of Clinical Operations at Aura Biosciences from January 2018 to January 2022. Rochelle possesses a Master’s degree in Cellular and Molecular Biology from the University of Michigan and a Bachelor of Arts in Chemistry from Kalamazoo College, both reflecting a strong academic foundation in the sciences.